January 2024
Parkinsons disease Diphasic Dyskinesia
Diphasic dyskinesia, characterized by two peaks of dyskinesia after levodopa doses, can be...
Parkinsons disease Wearing off Phenomena
Long-term levodopa use in Parkinson's disease can result in "wearing off" motor fluctuatio...
Parkinsons disease Peak dose Dyskinesia
Dyskinesia, often due to excessive dopamine stimulation, occurs after levodopa intake. Tre...
Parkinsons disease Recurrent Off periods
Effective treatments for reducing "off" periods in Parkinson's disease include carbidopa/l...
Parkinsons disease Basic Management
Parkinson's disease treatment involves non-pharmacological approaches like exercise, occup...
Serotonin Syndrome
Serotonin syndrome, potentially life-threatening, results from excess serotonergic activit...
Neuroleptic Malignant Syndrome
Neuroleptic malignant syndrome (NMS) is a life-threatening condition associated with antip...
Tic Disorders
Tics, common in Tourette syndrome (TS), are managed with education, behavioral therapy (HR...
Hemichorea
Hemichorea is characterized by one-sided involuntary movements and can result from various...
Chorea
Chorea is a hyperkinetic movement disorder with various causes. Treatment depends on the u...
Essential Tremor
Essential Tremor (ET) is a common cause of action tremor. Mild cases may not require treat...
Dystonia new
Dystonia is an extrapyramidal disorder characterized by repetitive muscle contractions lea...
Dopa Responsive Dystonia
Dopa Responsive Dystonia (DRD), resembling juvenile Parkinson's, is effectively treated wi...
Dyskinesias
Dyskinesias include acute dyskinesia from dopamine blockers in Parkinson's, tardive dyskin...
Tardive Dyskinesia
Tardive dyskinesia, a result of long-term anti-dopaminergic medication use, is treated by...
Antimyelin Oligodendrocyle Glycoprotein Demyelination
MOG antibody-related disorders, linked to demyelinating conditions like ADEM and NMOSD, ar...
Chronic Relapsing Inflammatory Optic Neuropathy
Chronic Relapsing Inflammatory Optic Neuropathy (CRION) is a rare autoimmune optic neuriti...
Acute Transverse Myelitis
Acute Transverse Myelitis, causing spinal cord inflammation, is treated with high-dose int...
Neuromyelitis Optica
NMOSD, distinct from MS, is marked by AQP4 antibodies causing optic neuritis and myelitis....
PML and JCV titers
Progressive multifocal leukoencephalopathy (PML), caused by John Cunningham virus reactiva...
Multiple sclerosis Spasticity and Pain
Spasticity in MS, manifesting as resistance to movement or involuntary jerks, is managed w...
Multiple sclerosis Cognition and Ambulation issues
Cognitive impairment in MS, manifesting as inattention and memory issues, is managed with...
Multiple sclerosis Bladder and Bowel issues
In MS, neurogenic bladder dysfunction causes urinary frequency and urgency, often worsened...
Multiple sclerosis Tysabri protocol and monitoring
Natalizumab, given as a 300 mg IV infusion every four weeks, can cause infusion reactions,...
Multiple sclerosis Tecfidera protocol and monitoring
Dimethyl fumarate, initially dosed at 120 mg twice daily and then increased to 240 mg, may...
Multiple sclerosis Ocrevus protocol and monitoring
Ocrelizumab, used for B cell depletion, has risks of infusion reactions, infections, and l...
Complex regional pain syndrome - 2
CRPS Type II, following nerve injury, often affects upper limbs, causing burning pain and...
Complex regional pain syndrome - 1
Complex Regional Pain Syndrome (CRPS), often post-injury, involves sensory, autonomic, and...
Thalamic Pain Syndrome
Thalamic Pain Syndrome, often post-stroke, manifests with delayed neuropathic pain, temper...
Multiple sclerosis Betaseron protocol and monitoring
Interferon beta-1b for MS is given subcutaneously every other day, with dose titration. Co...